Docetaxel

Страна: Нова Зеландія

мова: англійська

Джерело: Medsafe (Medicines Safety Authority)

Активний інгредієнт:

Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg

Доступна з:

REX Medical Ltd

ІПН (Міжнародна Ім'я):

Docetaxel trihydrate 25.177 mg (equivalent to anhydrous docetaxel 20mg)

Дозування:

20 mg/mL

Фармацевтична форма:

Concentrate for infusion

Склад:

Active: Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Одиниць в упаковці:

Vial, glass, Diluent, 1.5 mL

Клас:

Prescription

Тип рецепту:

Prescription

Виробник:

Cipla Ltd

Терапевтичні свідчення:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Огляд продуктів:

Package - Contents - Shelf Life: Vial, glass, Diluent - 1.5 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 20 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Дата Авторизація:

2006-06-23